Nephrogenetics and Kidney Genomics—the Future Is Now?

Dear Colleagues,

Monogenic and oligogenic forms of kidney disease are an important cause of kidney disease in adults and children with prevalence estimates emerging in recent years. The pace of molecular characterization and discovery in the space of heritable and genetic forms of kidney disease has been significant in recent years. Translation into clinical diagnostic offerings is generating global impact even as longitudinal clinical utility is being explored. Directed therapies are also beginning to emerge for several genetic kidney disorders across the broad spectrum of preclinical studies, clinical trials and also implementation into practice. With our increasing understanding, acceleration of the discovery and clinical translation in a multidisciplinary and patient centric manner is critical to realizing community and global benefit delivered by clinicians, researchers, industry and health systems.

In this Special Issue, we welcome reviews and original articles in regard to all facets of the study of genetic forms of kidney disease. These include, but are not limited to, genetic and genomic characterization (including epidemiology, case series and novel case reports), molecular mechanisms of disease, clinical genomics, research genomics, functional genomics, preclinical research, clinical studies and trials. We look forward to your contributions, which we hope will inform further progress in the area.

Prof. Dr. Andrew Mallett
Prof. Dr. Zornitza Stark
Dr. Amali Mallawaarachchi
Guest Editors